Search results
We’ve Hit Peak Theater
Vulture· 5 days agoOne of the last premiere parties of the Broadway season felt a little on the nose. The Great Gatsby, a ballad-belting, pyrotechnic glow-up of F. Scott...
Immunotherapy may boost survival after lung cancer surgery
UPI· 5 days agoImmunotherapy can boost the survival of early-stage lung cancer patients eligible for surgery when...
'Heart-in-a-box' technology lets Canadian organ donor save a life
CBC via Yahoo News· 5 days agoWhen Robbie died on May 7, he became the first Canadian adult to donate his heart after cardiac or...
Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital...
Nature· 1 day agoIdentifying biomarkers associated with risk of severe COVID-19 disease could inform clinical management. Here, the authors identify a long noncoding RNA associated with severe ...
Brazil’s floods smashed through barriers designed to keep them out, trapping water in for weeks —...
CNN via Yahoo News· 3 days ago“This was a completely unusual situation, a record situation, but unfortunately, because of what we...
FDA Broadens Breyanzi's Follicular Lymphoma Indication
Medscape· 5 days agoThe overall response rate to the CAR T therapy was 95.7% in phase 2 testing.
UC San Diego research study: Plant virus effective in fighting cancer
Channel 8 San Diego· 4 days agoNew research from UC San Diego has found an innovative new treatment to fight cancer. Researchers...
No Improvement in OS With Atezolizumab in Relapsing TNBC
Medscape· 5 days agoEarly relapsing disease has again shown the limitations of immunotherapy in triple-negative breast...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 10 hours agoAustin, TX, USA, May 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Non-Small-Cell Lung Cancer Drug Market Size, Trends and Insights By Cancer Type (Non-Small Cell Lung Cancer, Metastatic Lung
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 4 days agoThis indication is approved under accelerated approval based on response rate and duration of...
